Assessing the economic impact of chronic conditions in postmenopausal women

Author： Sasser Alicia C   Taylor Maida   Birnbaum Howard G   Schoenfeld Michael J   Oster Emily F   Rousculp Matthew  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.6, Iss.11, 2005-09, pp. : 1803-1814

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Economic Impact of Tibolone Compared with Continuous-Combined Hormone Replacement Therapy: In the Management of Postmenopausal Women with Climacteric Symptoms in the UK

By Plumb J.M.   Guest J.F.  

PharmacoEconomics, Vol. 18, Iss. 5, 2000-11 ,pp. : 477-486

Adis International

Access to resources Recommend Favorite

An economic analysis of hormone replacement therapy for the prevention of fracture in young postmenopausal women

By Lamy Olivier   Krieg Marc-Antoine   Burckhardt Peter   Wasserfallen Jean-Blaise  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 9, 2003-09 ,pp. : 1479-1488

Informa Healthcare

Access to resources Recommend Favorite

Assessing the economic impact of psychiatric disorders: where to begin?

By Greenberg P.E.   Leong S.A.   Birnbaum H.G.  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 4, 2001-04 ,pp. : 641-652

Informa Healthcare

Access to resources Recommend Favorite

Assessing the Economic Impact of Adverse Drug Effects

By Rodríguez-Monguió R.  

PharmacoEconomics, Vol. 21, Iss. 9, 2003-01 ,pp. : 623-650

Adis International

Access to resources Recommend Favorite

The economic impact of chronic obstructive pulmonary disease

By Hilleman Daniel E   Faulkner Michele A  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 3, 2002-03 ,pp. : 219-228

Informa Healthcare

Access to resources Recommend Favorite